Polyhydroxyalkanoate medical textiles and fibers
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61F-002/00
A61L-027/18
A61L-031/06
D01F-006/62
D01F-006/84
D01D-005/088
D01D-005/16
D02G-003/02
A61L-027/48
D01D-005/098
출원번호
US-0228056
(2011-09-08)
등록번호
US-9125719
(2015-09-08)
발명자
/ 주소
Martin, David P.
Rizk, Said
Ahuja, Ajay
Williams, Simon F.
출원인 / 주소
Tepha, Inc.
대리인 / 주소
Pabst Patent Group LLP
인용정보
피인용 횟수 :
0인용 특허 :
134
초록▼
Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate. These devices provide a wider range of in vivo strength retention properties than a
Absorbable polyester fibers, braids, and surgical meshes with prolonged strength retention have been developed. These devices are preferably derived from biocompatible copolymers or homopolymers of 4-hydroxybutyrate. These devices provide a wider range of in vivo strength retention properties than are currently available, and could offer additional benefits such as anti-adhesion properties, reduced risks of infection or other post-operative problems resulting from absorption and eventual elimination of the device, and competitive cost. The devices may also be particularly suitable for use in pediatric populations where their absorption should not hinder growth, and provide in all patient populations wound healing with long-term mechanical stability. The devices may additionally be combined with autologous, allogenic and/or xenogenic tissues to provide implants with improved mechanical, biological and handling properties.
대표청구항▼
1. An oriented melt extruded polymeric fiber, wherein the polymer consists of a poly-4-hydroxybutyrate homopolymer, wherein the fiber has a tensile strength between a tensile strength greater than 126 MPa and 739 MPa, and wherein the fiber is prepared by a method comprising melt extrusion, allowing
1. An oriented melt extruded polymeric fiber, wherein the polymer consists of a poly-4-hydroxybutyrate homopolymer, wherein the fiber has a tensile strength between a tensile strength greater than 126 MPa and 739 MPa, and wherein the fiber is prepared by a method comprising melt extrusion, allowing the extrudate dwell time to crystallize and drawing the fiber. 2. The fiber of claim 1 wherein the weight average molecular weight of the fiber decreases less than 80% after implantation for 6 months. 3. The fiber of claim 1 wherein the weight average molecular weight of the fiber decreases less than 75% after implantation for 2 weeks. 4. The fiber of claim 1 wherein the tensile strength of the fiber decreases less than 80% after implantation for 6 months. 5. The fiber of claim 1 wherein the tensile strength of the fiber decreases less than 75% after implantation for 2 weeks. 6. The fiber of claim 1 wherein the elongation to break is over 20%. 7. The fiber of claim 1 wherein the fiber is a monofilament, multifilament, or braided structure. 8. A device comprising one or more oriented melt extruded polymeric fibers wherein the polymer consists of a poly-4-hydroxybutyrate homopolymer, having a tensile strength between a tensile strength greater than 126 MPa and 739 MPa, and wherein the fiber is prepared by a method comprising melt extrusion, allowing the extrudate dwell time to crystallize and drawing the fiber, selected from the group consisting of a medical textile, tube, general surgical mesh, hernia mesh, breast reconstruction mesh, mastopexy mesh, pericardial patch, anti-adhesion patch, cardiovascular patch, guided tissue regeneration patch, sling, monofilament suture, multifilament suture, braid, ligament, tendon, meniscus repair device, cartilage repair device, nerve guide, stent, vascular graft, and dura. 9. The device of claim 8 wherein the device is a knitted mesh, woven mesh, or nonwoven mesh. 10. The device of claim 8 wherein the weight average molecular weight of the fiber in the device decreases less than 80% after implantation for 6 months. 11. The device of claim 8 wherein the weight average molecular weight of the fiber in the device decreases less than 75% after implantation for 2 weeks. 12. The device of claim 8 wherein the tensile strength of the fiber in the device decreases less than 80% after implantation for 6 months. 13. The device of claim 8 wherein the tensile strength of the fiber in the device decreases less than 50% after implantation for 2 weeks. 14. The device of claim 8 wherein the breaking strength of the device is at least 10 psi. 15. The device of claim 8 further comprising harvested autologous tissue, allogenic tissue, or xenogenic tissue. 16. The device of claim 15 wherein the device reinforces, supports, strengthens, or stiffens the autologous, allogenic, and/or xenogenic tissues. 17. The device of claim 16 wherein the device stiffens the tissue to facilitate implantation. 18. The device of claim 15 wherein the harvested autologous tissue, allogenic tissue, or xenogenic tissues is selected from the group consisting of vascular grafts, heart valves, pericardium, skin, intestine, muscle, ligament and tendon, cartilage and meniscus, nerves, dura, fascia, and organs. 19. . An oriented melt extruded polymeric fiber wherein the polymer consists of a poly-4-hydroxybutyrate homopolymer wherein the fiber is produced by a method comprising drying the polymer, extruding the polymer at a temperature between 100° C. and 220° C., allowing the polymer time to crystallize, and then drawing the polymer to stretch ratios from 6 to 11X at a temperature above the polymer's glass transition temperature.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (134)
Stack Richard S. (Chapel Hill NC) Klopovic Zenaida P. (Durham NC), Absorbable stent.
Urquhart John (Palo Alto CA) Chandrasekaran Santosh Kumar (Palo Alto CA) Shaw Jane Elizabeth (Atherton CA), Bandage for transdermally administering scopolamine to prevent nausea.
Nishida Haruo,JPX ; Yamashita Mitsuhiro,JPX ; Hattori Norikazu,JPX ; Ochi Yoshiki,JPX ; Kuwaki Tetsuo,JPX, Biodegradable alipathic polyster, melt-extrusion film thereof, and process for the production thereof.
Della Valle Francesco,ITX ; Romeo Aurelio,ITX ; Callegaro Lanfranco,ITX, Biodegradable and bioabsorbable guide channels for use in nerve treatment and regeneration.
Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David D. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dunn Richard L. (Fort Collins CO) English James P. (Birmingham AL) Cowsar Donald R. (Birmingham AL) Vanderbilt David P. (Birmingham AL), Biodegradable in-situ forming implants and methods of producing the same.
Dehennau Claude (Waterloo BEX) Depireux Thierry (Waterloo BEX) Fleche Guy (Hazebrouck FRX) Gosset Serge (Lestrem FRX) Videau Didier (Lille FRX), Biodegradable moulding compositions comprising a starch, a biodegradable polyester, and a salt of a hydroxycarboxylic ac.
Mao, Hai-Quan; Leong, Kam W.; Dang, Wenbin; Lo, Hungnan; Zhao, Zhong; Nowotnik, David P.; English, James P., Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same.
Huisman Gjalt W. ; Skraly Frank ; Martin David P. ; Peoples Oliver P., Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids.
Hlavacek Robert A. (New Haven CT) Dumican Barry L. (Fairfield CT) McCusker Edward J. (Fairfield CT), Flat braided ligament or tendon implant device having texturized yarns.
Wallace Donald G. (Menlo Park) McMullin Hugh (Pacifica) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Scopelianos Angelo G. ; Arnold Steven C. ; Bezwada Rao S. ; Roller Mark B. ; Huxel Shawn T., Injectable microdipersions for soft tissue repair and augmentation.
Trml Pertti (Tampere FIX) Rokkanen Pentti (Helsinki FIX) Laiho Juha (Tampere FIX) Tamminmki Markku (Tampere FIX) Vainionp Seppo (Helsinki FIX), Material for osteosynthesis devices.
Williams, Simon F.; Martin, David P.; Gerngross, Tillman; Horowitz, Daniel M., Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin.
Snell Kristi D. ; Hogan Scott A. ; Sim Sang Jun,KRX ; Sinskey Anthony J. ; Rha Chokyun, Method for controlling molecular weight of polyhydroxyalkanoates.
Williams,Simon F.; Martin,David P.; Gerngross,Tillman; Horowitz,Daniel M., Method for making devices using polyhydroxyalkanoate having pyrogen removed.
Peoples Oliver P. (Arlington MA) Gerngross Tillman U. (Cambridge MA) Sinskey Anthony J. (Boston MA), Overproduction and purification of soluble PHA synthase.
Gallagher Francis G. (Wilmington DE) Hamilton Cathy J. (Wilmington DE) Hansen Steven M. (Kinston NC) Shin Hyunkook (Wilmington DE) Tietz Raymond F. (Wilmington DE), Polyesters and their use in compostable products such as disposable diapers.
Witholt Bernard (Eelde NLX) Lageveen Roland G. (Groningen NLX), Process for producing polyesters by fermentation: a process for producing optically active carboxylic acids and esters:.
Williams Simon F. ; Martin David P. ; Gerngross Tillman ; Horowitz Daniel M., Removing endotoxin with an oxdizing agent from polyhydroxyalkanoates produced by fermentation.
Gogolewski Sylwester (Alvaneu CHX) Perren Stephan M. (Davos CHX), Resorbable fixation device with controlled stiffness for treating bodily material in vivo and introducer therefor.
Mahmood, Tahir; Riesle, Jens Uwe; van Blitterswijk, Clemens Antoni, Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material.
Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
Trml Pertti (Reikonkatu 7 C 7 ; SF-33730 Tampere FIX) Rokkanen Pentti (Marjaniemenranta 29 ; SF-00930 Helsinki FIX) Vainionp Seppo (Orapihlajhatie 21-27 B 12 ; SF-00320 Helsinki FIX) Laiho Juha (Pirk, Surgical materials and devices.
Chandrasekaran Santosh K. (Palo Alto CA) Darda Siegfried (Ingelheim am Rhein CA DEX) Michaels Alan S. (Atherton CA) Cleary Gary W. (Palo Alto CA), Therapeutic system for administering clonidine transdermally.
Gale Robert M. (Los Altos CA) Goetz Victor (Palo Alto CA) Lee Eun S. (Redwood City CA) Taskovich Lina T. (Palo Alto CA) Yum Su I. (Los Altos CA), Transdermal administration of fentanyl and device therefor.
Gale Robert M. (Los Altos CA) Enscore David J. (Sunnyvale CA) Nedberge Diane E. (Los Altos CA) Nelson Melinda (Sunnyvale CA) Cheng Yu-Ling (Cupertino CA) Libicki Shari B. (Palo Alto CA), Transdermal administration of progesterone, estradiol esters, and mixtures thereof.
Nedberge Diane E. (Los Altos CA) Campbell Patricia S. (Palo Alto CA) Gale Robert M. (Los Altos CA) Yum Su I. (Los Altos CA), Transdermal contraceptive formulations.
Chen Yu-Ling (Cupertino CA) Chun Leslie L. (Palo Alto CA) Enscore David J. (Sunnyvale CA), Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.